A Study Evaluating the Safety, Tolerability, and Pharmacodynamic Effects of GLY-200 in Type 2 Diabetic Patients

Clinical trial NCT05478525 · COMPLETED

Trial details

NCT number: NCT05478525
Sponsor: Glyscend, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2022-08-03
Primary completion: 2023-03-14
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.